Bococizumab is a novel anti-PCSK9 antibody effectively developed to combat hypercholesterolemia. Such therapeutic agent works by the PCSK9 protein, a critical regulator of cholesterol concentrations. By blocking the https://bookmark-template.com/story28242153/bococizumab-a-novel-anti-pcsk9-antibody-for-hypercholesterolemia